Immunovia Provides Forth Update During COVID-19 Pandemic
Immunovia™ Dx Laboratories in Marlborough, Massachusetts Reopens LUND, SWEDEN – Immunovia AB (publ) (“Immunovia”) today provides an update on the actions that the company is taking in response to the coronavirus (COVID-19) pandemic. During these challenging times, Immunovia remains focused on the sales start of the first-to-market test for early diagnosis of pancreatic cancer, IMMray™ PanCan-d. Governor Baker of Massachusetts, USA issued a four-phase approach to reopening plan. In the first phase, that began on Monday, May 18, 2020, limited industries were able to resume operations,